AIMS/HYPOTHESIS: Peroxisome proliferator-activated receptor (PPAR)-gamma coactivator-1 (PPARGC1), a coactivator regulating the transcription of genes involved in oxidative metabolism, is downregulated in patients with type 2 diabetes and in their first-degree relatives. Whether this downregulation is a cause or effect of early aberrations in the development of insulin resistance, such as disturbances in fat metabolism, is unknown. We examined whether lipid-induced insulin resistance was associated with downregulation of expression of skeletal muscle genes involved in oxidative metabolism and mitochondrial biogenesis in humans. MATERIALS AND METHODS: Nine healthy lean male subjects underwent a 6-h hyperinsulinaemic-euglycaemic clamp with simultaneous infusion of either a lipid emulsion or glycerol as a control. Blood was sampled at regular time points and muscle biopsies were taken before and after every test. Intramuscular triacylglycerol (IMTG) content was determined by Oil Red O staining and gene expression was measured by quantitative PCR. RESULTS: Lipid infusion resulted in a approximately 2.7-fold increase in plasma NEFA levels and a 31+/-6% decrease in insulin sensitivity (p=0.001). The infusion of lipids resulted in a approximately 1.6-fold increase in IMTG (p=0.02), whereas during the clamp with glycerol infusion IMTG tended to decrease to approximately 53% of preinfusion levels (p=0.065). Lipid infusion decreased PPARGC1A, PPARGC1B and PPARA expression to approximately 61, 77 and approximately 52% of basal values respectively, whereas expression of uncoupling protein 3 was upregulated 1.8-fold (all p<0.05). CONCLUSIONS/ INTERPRETATION: Acute elevation of plasma NEFA levels, leading to muscular fat accumulation and insulin resistance, downregulates PPARGC1A, PPARGC1B and PPARA expression, suggesting that the decrease in PPARGC1 expression observed in the (pre)diabetic state may be the result, rather than the cause of lipid-induced insulin resistance.
AIMS/HYPOTHESIS: Peroxisome proliferator-activated receptor (PPAR)-gamma coactivator-1 (PPARGC1), a coactivator regulating the transcription of genes involved in oxidative metabolism, is downregulated in patients with type 2 diabetes and in their first-degree relatives. Whether this downregulation is a cause or effect of early aberrations in the development of insulin resistance, such as disturbances in fat metabolism, is unknown. We examined whether lipid-induced insulin resistance was associated with downregulation of expression of skeletal muscle genes involved in oxidative metabolism and mitochondrial biogenesis in humans. MATERIALS AND METHODS: Nine healthy lean male subjects underwent a 6-h hyperinsulinaemic-euglycaemic clamp with simultaneous infusion of either a lipid emulsion or glycerol as a control. Blood was sampled at regular time points and muscle biopsies were taken before and after every test. Intramuscular triacylglycerol (IMTG) content was determined by Oil Red O staining and gene expression was measured by quantitative PCR. RESULTS:Lipid infusion resulted in a approximately 2.7-fold increase in plasma NEFA levels and a 31+/-6% decrease in insulin sensitivity (p=0.001). The infusion of lipids resulted in a approximately 1.6-fold increase in IMTG (p=0.02), whereas during the clamp with glycerol infusion IMTG tended to decrease to approximately 53% of preinfusion levels (p=0.065). Lipid infusion decreased PPARGC1A, PPARGC1B and PPARA expression to approximately 61, 77 and approximately 52% of basal values respectively, whereas expression of uncoupling protein 3 was upregulated 1.8-fold (all p<0.05). CONCLUSIONS/ INTERPRETATION: Acute elevation of plasma NEFA levels, leading to muscular fat accumulation and insulin resistance, downregulates PPARGC1A, PPARGC1B and PPARA expression, suggesting that the decrease in PPARGC1 expression observed in the (pre)diabetic state may be the result, rather than the cause of lipid-induced insulin resistance.
Authors: Dawn K Richardson; Sangeeta Kashyap; Mandeep Bajaj; Kenneth Cusi; Steven J Mandarino; Jean Finlayson; Ralph A DeFronzo; Christopher P Jenkinson; Lawrence J Mandarino Journal: J Biol Chem Date: 2004-12-14 Impact factor: 5.157
Authors: Martin D Brand; Julie A Buckingham; Telma C Esteves; Katherine Green; Adrian J Lambert; Satomi Miwa; Michael P Murphy; Julian L Pakay; Darren A Talbot; Karim S Echtay Journal: Biochem Soc Symp Date: 2004
Authors: S Jacob; J Machann; K Rett; K Brechtel; A Volk; W Renn; E Maerker; S Matthaei; F Schick; C D Claussen; H U Häring Journal: Diabetes Date: 1999-05 Impact factor: 9.461
Authors: Jiandie Lin; Hai Wu; Paul T Tarr; Chen-Yu Zhang; Zhidan Wu; Olivier Boss; Laura F Michael; Pere Puigserver; Eiji Isotani; Eric N Olson; Bradford B Lowell; Rhonda Bassel-Duby; Bruce M Spiegelman Journal: Nature Date: 2002-08-15 Impact factor: 49.962
Authors: Aline Meirhaeghe; Vivion Crowley; Carol Lenaghan; Christopher Lelliott; Kath Green; Abigail Stewart; Kevin Hart; Sven Schinner; Jaswinder K Sethi; Giles Yeo; Martin D Brand; Ron N Cortright; Stephen O'Rahilly; Carl Montague; Antonio J Vidal-Puig Journal: Biochem J Date: 2003-07-01 Impact factor: 3.857
Authors: Miranda Nabben; Bianca W J van Bree; Ellen Lenaers; Joris Hoeks; Matthijs K C Hesselink; Gert Schaart; Marion J J Gijbels; Jan F C Glatz; Gustavo J J da Silva; Leon J de Windt; Rong Tian; Elise Mike; Darlene G Skapura; Xander H T Wehrens; Patrick Schrauwen Journal: Basic Res Cardiol Date: 2014-10-25 Impact factor: 17.165
Authors: Alexis C Frazier-Wood; Stella Aslibekyan; Ingrid B Borecki; Paul N Hopkins; Chao-Qiang Lai; Jose M Ordovas; Robert J Straka; Hemant K Tiwari; Donna K Arnett Journal: Pharmacogenet Genomics Date: 2012-10 Impact factor: 2.089
Authors: Paul W Franks; Costas A Christophi; Kathleen A Jablonski; Liana K Billings; Linda M Delahanty; Edward S Horton; William C Knowler; Jose C Florez Journal: Diabetologia Date: 2013-12-07 Impact factor: 10.122
Authors: Joris Hoeks; Noud A van Herpen; Marco Mensink; Esther Moonen-Kornips; Denis van Beurden; Matthijs K C Hesselink; Patrick Schrauwen Journal: Diabetes Date: 2010-06-23 Impact factor: 9.461
Authors: Ian R Lanza; Agnieszka Blachnio-Zabielska; Matthew L Johnson; Jill M Schimke; Daniel R Jakaitis; Nathan K Lebrasseur; Michael D Jensen; K Sreekumaran Nair; Piotr Zabielski Journal: Am J Physiol Endocrinol Metab Date: 2013-04-30 Impact factor: 4.310